In This Section

Pharmacology Repurposed: Novel Uses for Current Therapies

Tuesday April 09, 2019

2:00 pm - 3:30 pm

Room W205 A
Sponsored by the Division for Drug Discovery and Development (DDD)
Co-sponsored by the Division for Cardiovascular Pharmacology (CVP)
Co-sponsored by the Division for Pharmacology Education (DPE)
Co-sponsored by the Division for Translational and Clinical Pharmacology (TCP)

Chair :

Joseph Provost
University of San Diego

Margaret Zimmerman
Tulane Univ


Many therapeutic agents are being repurposed, a process that uses a drug already approved to treat one condition/disease and safely applying it to another. The incorporation of repurposed drugs can be applied at all levels of research and promotes the development of new therapeutic approaches. Additionally, this methodology encourages researchers to investigate alternative pathways when targeting diseases. The goal of this symposium is to highlight both clinical and basic researchers that are using this approach, and to promote the NIH NCATS program which supports clinical and translational research in drug repurposing.

NO More PDE5 in PE: Repurposing Sildenafil for Treatment of Preeclampsia
Jennifer Sasser - University of Mississippi Medical Center

Repurposing GPCRs to Regulate YAP/TAZ in Tissue Fibrosis
Andrew Haak - Mayo Clinic

Last Updated: August 15, 2019
Key Dates
April 6

ASPET Business Meeting and Awards Presentation

April 6-9

ASPET Annual Meeting at EB 2019

Thank you to our Annual Meeting partners:

Amgen
University of Florida
Wake Forest University
Washington State University College of Pharmacy and Pharmaceutical Sciences
University of Wisconsin Molecular and Cellular Pharmacology Training Program
UT Health San Antonio
University of Minnesota

Emory University Pharmacology

PR & P
University of Michigan Medical School Pharmacology
jpet_banner
molpharm_banner
dmd_banner
pharmrev_banner